30-06-2023 22:46:05 | Current | EBI | 13/2023
The Management Board of Mycodern S.A., headquartered in Gdansk, in reference to the current report EBI No. 1/2023 dated January 31, 2023, in which it provided the schedule for the publication of periodic reports in 2023, as well as EBI reports No. 7/2023 dated May 31, 2023, 9/2023 dated June 5, 2023, 10/2023, dated June 10, 2023, and 11/2023, dated June 19, 2023, in which it announced changes to the publication dates of the separate and consolidated annual reports for 2022, hereby announces another change to the publication dates of these reports and the setting of a new publication date of July 7, 2023.
At the same time, the Board of Directors informs that it is in violation of its information obligation due to the failure to provide this report on the change of the publication date of these annual reports for 2022 at least 2 days before the previously announced date of their publication, which was today. The Board of Directors informs that the change of the publication date of the separate and consolidated annual reports for 2022 is due to prolonged work on the preparation of these reports.Legal basis:
– § 6 section 14.2 of Appendix No. 3 to the Regulations of the Alternative Trading System “Current and periodic information provided in the alternative trading system on the NewConnect market”,
– Section 16a of Appendix No. 1 to Resolution No. 795/2008 of the Warsaw Stock Exchange Management Board dated October 31, 2008. “Good practices of companies listed on NewConnect” (as amended by Resolution No. 293/2010 of the Management Board of the Warsaw Stock Exchange SA of March 31, 2010 on the amendment of the document “Good practices of companies listed on NewConnect”).
- Piotr Zawadzki – President of the Management Board
2023. Mycodern S.A.